Carcinoma Clinical Trials

Active, not recruiting

Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

NCT01142388

Conditions: Adenocarcinoma Of Esophagus, Carcinoma, Carcinoma, Squamous Cell, +21 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Stanford Cancer Institute Palo Alto Palo Alto, California, United States

The Medical Center of Aurora Aurora, Colorado, United States

Boulder Community Foothills Hospital Boulder, Colorado, United States

View all 232 locations

View Trial Details

Active, not recruiting

Testing the Addition of M6620 (VX-970, Berzosertib) to Usual Chemotherapy and Radiation for Head and Neck Cancer

NCT02567422

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Carcinoma of Unknown Primary, +17 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

University of California Davis Comprehensive Cancer Center Sacramento, California, United States

Smilow Cancer Center/Yale-New Haven Hospital New Haven, Connecticut, United States

Yale University New Haven, Connecticut, United States

View all 19 locations

View Trial Details

Active, not recruiting

Testing the Addition of Tazemetostat to the Immunotherapy Drug, Pembrolizumab (MK-3475), in Advanced Urothelial Carcinoma

NCT03854474

Conditions: Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +16 more
Locations: Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States

Mayo Clinic in Arizona Scottsdale, Arizona, United States

Smilow Cancer Hospital-Derby Care Center Derby, Connecticut, United States

Smilow Cancer Hospital Care Center-Fairfield Fairfield, Connecticut, United States

View all 34 locations

View Trial Details

Active, not recruiting

Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver

NCT04175912

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +24 more
Locations: Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States

Anchorage Radiation Therapy Center Anchorage, Alaska, United States

Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States

Alaska Oncology and Hematology LLC Anchorage, Alaska, United States

View all 419 locations

View Trial Details

Active, not recruiting

Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study

NCT04071223

Conditions: Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +22 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

UC San Diego Moores Cancer Center La Jolla, California, United States

University of California Davis Comprehensive Cancer Center Sacramento, California, United States

Rush MD Anderson Cancer Center Chicago, Illinois, United States

View all 47 locations

View Trial Details

Active, not recruiting

Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy

NCT04963153

Conditions: Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +36 more
Locations: Los Angeles General Medical Center Los Angeles, California, United States

USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

UCHealth University of Colorado Hospital Aurora, Colorado, United States

Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Active, not recruiting

Sapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 Mutations

NCT03047213

Conditions: Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +18 more
Locations: Los Angeles General Medical Center Los Angeles, California, United States

USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

Keck Medical Center of USC Pasadena Pasadena, California, United States

University of California Davis Comprehensive Cancer Center Sacramento, California, United States

View all 20 locations

View Trial Details

Active, not recruiting

Testing the Combination of XL184 (Cabozantinib), Nivolumab, and Ipilimumab for Poorly Differentiated Neuroendocrine Tumors

NCT04079712

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +20 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

Banner University Medical Center - Tucson Tucson, Arizona, United States

University of Arizona Cancer Center-North Campus Tucson, Arizona, United States

City of Hope Comprehensive Cancer Center Duarte, California, United States

View all 46 locations

View Trial Details

Active, not recruiting

Testing AZD1775 in Advanced Solid Tumors That Have a Mutation Called SETD2

NCT03284385

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +24 more
Locations: UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States

University of California Davis Comprehensive Cancer Center Sacramento, California, United States

UCSF Medical Center-Mount Zion San Francisco, California, United States

UCSF Medical Center-Mission Bay San Francisco, California, United States

View all 29 locations

View Trial Details

Active, not recruiting

An Early Access Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic Cholangiocarcinoma

NCT05876754

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +3 more
Locations: Erebouni MC Yerevan, Armenia

National Center of Oncology of Ra M Yerevan, Armenia

Royal brisbane & Women's Hospital Brisbane, Australia

St Vincent's Hospital Fitzroy, Australia

View all 84 locations

View Trial Details

Carcinoma

Carcinoma trial results

Related conditions